# SS-31 Side Effects: What Studies and Users Report | PepVault

Source: https://pepvault.app/peptides/ss-31/side-effects

Last updated: 2026-10-12

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [SS-31](https://pepvault.app/peptides/ss-31) Side effects

Peptide questions · SS-31

# SS-31 side effects: what studies and users report

Reviewed October 2026 Evidence: Emerging [Published by PepVault](https://pepvault.app/guides/how-we-research)

The side effects most commonly reported for SS-31 are injection site reaction, nausea and mild headache; the library’s evidence on it includes controlled trials in people.

The library holds no separate safety note for SS-31.

## What is commonly reported with SS-31

- Injection site reaction
- Nausea
- Mild headache

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other longevity compounds the library lists it for

| Effect | Also listed for (of 18) |
| --- | --- |
| Injection site reaction | 4: MOTS-c, Epitalon, Pinealon, Klotho |
| Nausea | None: listed for SS-31 alone |
| Mild headache | 2: Epitalon, DSIP |

<!--promo-->

PepVault for iPhone

## Track SS-31 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Which SS-31 side effects the longevity group shares

Across the 19 longevity compounds in the library, the effects listed most often are injection site reaction (5 of 19), injection-site discomfort (3 of 19), injection-site redness or itch (3 of 19) and mild headache (3 of 19). SS-31 shares 2 of its 3 listed effects with at least one other longevity compound; nausea is listed for SS-31 alone.

## More on SS-31

### SS-31

- [SS-31: the full reference](https://pepvault.app/peptides/ss-31)
- [SS-31 dose guide](https://pepvault.app/lab/dosage/ss-31)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-10mg)
- [50 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-50mg)

### Studies

- [SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024)
- [SS-31: no gain in walk distance or fatigue in the MMPOWER-3 trial](https://pepvault.app/research/ss-31-mmpower-3-2023)
- [SS-31: wearable data grouped responders with 100% accuracy](https://pepvault.app/research/ss-31-van-den-eynde-2023)
- [All 14 studies](https://pepvault.app/research#ss-31)

### Compared with

- [MOTS-c vs SS-31](https://pepvault.app/peptides/compare/mots-c-vs-ss-31)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### SS-31 questions

- [SS-31: how long it takes to work](https://pepvault.app/peptides/ss-31/how-long-to-work)
- [SS-31: what it’s stacked with](https://pepvault.app/peptides/ss-31/stacks)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Observational study](https://pepvault.app/glossary/observational-study)

## Where the SS-31 reports come from

The library rates the evidence on SS-31 as emerging: mostly preclinical, with limited human data.

Of the library’s 5 research notes on SS-31, 2 rest on clinical data and 3 on community reports.

Our 14 study pages on SS-31: 8 randomized trials, 2 clinical trials, 3 animal studies (mice) and 1 observational study.

So SS-31 has controlled trials in people to set its listed effects against.

## What our SS-31 study pages report on safety

### SS-31 (elamipretide) eye drops missed main vision goal in LHON trial

Randomized trial, human, 2024: Elamipretide was well tolerated, most side effects were mild to moderate and went away on their own, and there were no serious side effects.

- [Read the study page: SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024)

### SS-31: 96.1 m longer 6-minute walk at 168 weeks in TAZPOWER

Clinical trial, human, 2024: Elamipretide was well tolerated, and reactions at the injection site were the most common side effect. For Barth syndrome, this small extension suggests elamipretide's gains in walking distance and fatigue held up through 168 weeks, with injection-site reactions as the most common side effect.

- [Read the study page: SS-31: 96.1 m longer 6-minute walk at 168 weeks in TAZPOWER](https://pepvault.app/research/ss-31-tazpower-2024)

### SS-31: no gain in walk distance or fatigue in the MMPOWER-3 trial

Randomized trial, human, 2023: The drug was tolerated well, and most side effects were mild or moderate. In a large placebo-controlled trial, elamipretide was tolerated well but did not improve walking distance or fatigue over 24 weeks in primary mitochondrial myopathy.

- [Read the study page: SS-31: no gain in walk distance or fatigue in the MMPOWER-3 trial](https://pepvault.app/research/ss-31-mmpower-3-2023)

### SS-31: walk distance rose with dose in 5-day MMPOWER trial

Randomized trial, human, 2018: No significant differences showed up in the other efficacy measures or in safety. This was a small trial with only 5 days of treatment, so it can't show longer-term benefit or safety.

- [Read the study page: SS-31: walk distance rose with dose in 5-day MMPOWER trial](https://pepvault.app/research/ss-31-mmpower-2018)

### SS-31 did not significantly cut infarct size in EMBRACE STEMI

Randomized trial, human, 2016: SS-31 also did not improve the pre-planned MRI, angiography, ECG or clinical outcomes, and it was safe and well tolerated. In a randomized human trial in heart attack patients having PCI, SS-31 was well tolerated but did not significantly reduce heart muscle damage compared with placebo.

- [Read the study page: SS-31 did not significantly cut infarct size in EMBRACE STEMI](https://pepvault.app/research/ss-31-embrace-stemi-2016)

## Questions people ask

### What are the side effects of SS-31?

The side effects most commonly reported for SS-31 are injection site reaction, nausea and mild headache; the library’s evidence on it includes controlled trials in people.

### Do SS-31’s side effects come from human studies?

The library rates the evidence on SS-31 as emerging, and the library’s evidence on it includes controlled trials in people.

### Which SS-31 side effects are its own?

Among the longevity compounds, the library lists nausea for SS-31 alone.

## More on SS-31

- [SS-31: the full library page](https://pepvault.app/peptides/ss-31)
- [SS-31 dose guide](https://pepvault.app/lab/dosage/ss-31)
- [SS-31: how long it takes to work](https://pepvault.app/peptides/ss-31/how-long-to-work)
- [SS-31: what it’s stacked with](https://pepvault.app/peptides/ss-31/stacks)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track SS-31 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track SS-31 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on SS-31

### SS-31

- [SS-31: the full reference](https://pepvault.app/peptides/ss-31)
- [SS-31 dose guide](https://pepvault.app/lab/dosage/ss-31)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-10mg)
- [50 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-50mg)

### Studies

- [SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024)
- [SS-31: no gain in walk distance or fatigue in the MMPOWER-3 trial](https://pepvault.app/research/ss-31-mmpower-3-2023)
- [SS-31: wearable data grouped responders with 100% accuracy](https://pepvault.app/research/ss-31-van-den-eynde-2023)
- [All 14 studies](https://pepvault.app/research#ss-31)

### Compared with

- [MOTS-c vs SS-31](https://pepvault.app/peptides/compare/mots-c-vs-ss-31)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### SS-31 questions

- [SS-31: how long it takes to work](https://pepvault.app/peptides/ss-31/how-long-to-work)
- [SS-31: what it’s stacked with](https://pepvault.app/peptides/ss-31/stacks)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Observational study](https://pepvault.app/glossary/observational-study)

<!--promo-->

PepVault for iPhone

## Track SS-31 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## SS-31

- [SS-31 in the library](https://pepvault.app/peptides/ss-31)
- [SS-31: how long it takes to work](https://pepvault.app/peptides/ss-31/how-long-to-work)
- [SS-31: what it’s stacked with](https://pepvault.app/peptides/ss-31/stacks)

## Tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The peptide glossary](https://pepvault.app/glossary)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
